Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

news

Welcome to the PeriRx Newsroom where you will find the latest announcements, articles and media coverage regarding PeriRx and its salivary diagnostic tests. Simply click the individual titles below to view the complete article.

News

Coming Soon: PeriRx LLC’s Breakthrough Salivary Test to Aid in the Fight Against Oral Cancer

MarketwireThe World’s Most Clinically Advanced and Scientifically Validated Molecular DNA Biomarker Test for Oral Squamous Cell Carcinoma is Launching in Late Spring

HAVERTOWN, PA–(Marketwired – Apr 3, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology recently announced that it will be introducing the world’s most clinically advanced and scientifically validated molecular DNA biomarker test for oral squamous cell carcinoma detection in the late spring. [Read more…]

New Study Finds Clinical Screenings Poor Predictors of Oral Cancer

ASDAAccording to the National Cancer Institute, an estimated 40,250 people were diagnosed with cancer of the oral cavity and pharynx in the United States in 2012. The five-year survival rate for those diagnosed with early-stage oral and pharyngeal cancers is 82.4 percent. The five-year survival rate of those diagnosed with late-stage metastasized oral and pharyngeal cancers is 34.9 percent. [Read more…]

Molecular Saliva Test Detects Oral Cancer, Diabetes

2012_11_20_14_52_15_961_Neil_Gottehrer_175November 28, 2012 — A Pennsylvania start-up is gearing up to launch a molecular saliva test that analyzes biomarkers to detect oral cancer and diabetes. PeriRx is now conducting clinical trials of its diagnostic test, which has attracted the interest of the U.K.’s National Institute for Health Research.

The genesis for the test came from a collaboration between Neil Gottehrer, DDS, a Havertown, PA, dentist who has been practicing for 38 years, and David T.W. Wong, DMD, DMSc, a pioneer in salivary diagnostics who is the associate dean of research and a professor of oral biology at the University of California, Los Angeles (UCLA) School of Dentistry. [Read more…]

Cutting-edge Test Detects Cancer Cells in Saliva

558869_58064280-704x318In 2008, Pennsylvania doctors, Neil Gottehrer, DDS, and David T.W. Wong, DMD, DMSc, began collaborating on a project to develop a cutting-edge test that would analyze molecular biomarkers in saliva to detect oral cancer. Using Gottehrer’s 38 years of experience as a dentist and Wong’s pioneering research in salivary diagnostics, the two have successfully changed the way doctors, dentists and hygienists screen for oral cancer. [Read more…]

PeriRx Developing Cancer Tool for Dentists

PeriRx887HAVERTOWN — A personalized medicine company is out to make a trip to the dentist more meaningful than simply a checkup for cavities and a teeth cleaning.

PeriRx has licensed and is completing the development of a non-invasive saliva test for dentists that can be used to detect and predict oral cancer — the world’s sixth most common cancer.

Stephen M. Swanick, CEO of PeriRx, said the 4-year-old Delaware County company is in discussions with several large pharmaceutical companies, including GlaxoSm-thKline and Johnson & Johnson, about teaming up on the distribution of its molecular diagnostic test for oral cancer and a second product targeted the early diagnosis of diabetes. [Read more…]

Does race play a role in oral cancer surgery referrals?

DrBicuspid logoIt appears to, according to a study in Community Dentistry and Oral Epidemiology (August 24, 2011). White patients are twice as likely to be recommended for surgery for oral and oropharyngeal cancer as black patients, according to researchers from the Medical University of South Carolina. The researchers weren’t surprised to find racial discrimination in cancer treatment, but they didn’t expect it to be so prevalent, they said. [Read more…]